These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 27081861)
21. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression. Jiang C; Shen F; Du J; Fang X; Li X; Su J; Wang X; Huang X; Liu Z Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760 [TBL] [Abstract][Full Text] [Related]
22. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells. Ma J; Yang YR; Chen W; Chen MH; Wang H; Wang XD; Sun LL; Wang FZ; Wang DC Oncol Rep; 2016 Aug; 36(2):676-84. PubMed ID: 27278525 [TBL] [Abstract][Full Text] [Related]
23. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line. Yi GZ; Liu YW; Xiang W; Wang H; Chen ZY; Xie SD; Qi ST J Neurol Sci; 2016 Aug; 367():101-6. PubMed ID: 27423571 [TBL] [Abstract][Full Text] [Related]
24. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways. Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789 [TBL] [Abstract][Full Text] [Related]
25. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells. Rocha CR; Kajitani GS; Quinet A; Fortunato RS; Menck CF Oncotarget; 2016 Jul; 7(30):48081-48092. PubMed ID: 27344172 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma. Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370 [TBL] [Abstract][Full Text] [Related]
27. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels. Lu XY; Cao K; Li QY; Yuan ZC; Lu PS J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272 [TBL] [Abstract][Full Text] [Related]
28. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment. Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014 [TBL] [Abstract][Full Text] [Related]
29. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma. Kim SM; Woo JS; Jeong CH; Ryu CH; Jang JD; Jeun SS Stem Cells Transl Med; 2014 Feb; 3(2):172-82. PubMed ID: 24436439 [TBL] [Abstract][Full Text] [Related]
30. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2. Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476 [TBL] [Abstract][Full Text] [Related]
31. Bak and Mcl-1 are essential for Temozolomide induced cell death in human glioma. Gratas C; Séry Q; Rabé M; Oliver L; Vallette FM Oncotarget; 2014 May; 5(9):2428-35. PubMed ID: 24811082 [TBL] [Abstract][Full Text] [Related]
32. A positive feedback loop of lncRNA-RMRP/ZNRF3 axis and Wnt/β-catenin signaling regulates the progression and temozolomide resistance in glioma. Liu T; Hu J; Han B; Tan S; Jia W; Xin Y Cell Death Dis; 2021 Oct; 12(11):952. PubMed ID: 34657141 [TBL] [Abstract][Full Text] [Related]
33. Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity. Kumar DM; Patil V; Ramachandran B; Nila MV; Dharmalingam K; Somasundaram K Proteomics; 2013 Jul; 13(14):2113-24. PubMed ID: 23595970 [TBL] [Abstract][Full Text] [Related]
34. LncRNA-XIST interacts with Du P; Zhao H; Peng R; Liu Q; Yuan J; Peng G; Liao Y Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28831025 [TBL] [Abstract][Full Text] [Related]
35. Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway. Wang Q; Du J; Xu B; Xu L; Wang X; Liu J; Wang J Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):501-8. PubMed ID: 27189511 [TBL] [Abstract][Full Text] [Related]
36. Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy. Ming J; Sun B; Li Z; Lin L; Meng X; Han B; Wang R; Wu P; Li J; Cai J; Jiang C Aging (Albany NY); 2017 Apr; 9(4):1233-1247. PubMed ID: 28446712 [TBL] [Abstract][Full Text] [Related]
37. Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level. Gong A; Ge N; Yao W; Lu L; Liang H Cancer Chemother Pharmacol; 2014 Sep; 74(3):531-8. PubMed ID: 25047724 [TBL] [Abstract][Full Text] [Related]
38. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539 [TBL] [Abstract][Full Text] [Related]
39. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells. Wang Y; Gao S; Wang W; Liang J Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252 [TBL] [Abstract][Full Text] [Related]
40. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity. Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]